Publications, Pharmaceutical

An Eye on the Future of Preservative-Free Drops

In this article, Alexandra Ritter, Head of Regulatory Affairs and Combination Products, and Matthias Birkhoff, Vice-President Business Development, both at Aptar Pharma, discuss the value that Aptar Pharma’s regulatory support and services add to the filing process of a new eye care development, the challenges of administering a wider range of medications via topical eye drops and the benefits of preservative-free multidose ophthalmic drug-device combination products.

For more information on ONdrugDelivery.

 

Download Publication
Author(s): Alexandra Ritter Matthias Birkhoff
15 Mar 2022

Learn more about Ophthalmic Squeeze Dispenser

Find Out More About OSD

This Might Also Be of Interest

16 Dec 2020

COVID-19 intensifies need for and uptake of digital healthcare

Publications, Pharmaceutical, Innovation & Insights, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
5 Nov 2020

The Need to Scale Up Digital Health in the Post-Covid World

Webinars, Pharmaceutical, Innovation & Insights, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
5 Oct 2020

Reusable systems and recyclable packaging aid pharma sustainability

Publications, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions, Sustainability, Innovation & Insights

Read More
1 Jun 2020

Aptar Pharma expert Q&A on digital health and connected drug delivery

Publications, Pharmaceutical, Brand Differentiation, Product Solutions, Innovation & Insights, Device Innovations

Read More
1 2 3 4 5 6

Request Access

Close

Requesting access to An Eye on the Future of Preservative-Free Drops.

  • This field is for validation purposes and should be left unchanged.

How Can We Help?

Back To Top